Melanotan 2 (MT-2) is a synthetic cyclic analog of α-MSH that activates melanocortin receptors non-selectively. MC1R activation stimulates melanin production (the pigmentation/tanning effect), while MC4R activation underlies the appetite- and libido-related effects studied in research models. It is more potent and longer-acting than native α-MSH. It is not FDA-approved, and vendor-sold MT-2 is research-grade material; the related MC4R-selective agonist bremelanotide (PT-141) is a separate compound.

Research notes
How does Melanotan 2 work?
Melanotan 2 is a synthetic cyclic analog of α-MSH, engineered for potency and metabolic stability. It is a non-selective melanocortin-receptor agonist: activation of MC1R on melanocytes drives melanin synthesis (the pigmentation effect that gave the compound its name), while activation of MC4R in the central nervous system underlies the appetite-suppression and sexual-function signaling studied in research models.
Cyclization and a D-amino-acid substitution give it a much longer half-life and higher receptor affinity than native α-MSH, which is why it is used as a long-acting melanocortin reference compound.
What doses are used in research?
Research literature describes subcutaneous dosing in the microgram-to-low- milligram range. Research vials are commonly 10 mg. Reported research-context side effects include nausea, flushing, and darkening of existing nevi.
What does this guide cover?
MT-2 is sold under several labels ("MT-2", "Melanotan II"), so identity confirmation against the COA matters. We weight COA-verified purity and identity and flag listings that publish no per-batch report.
Is Melanotan 2 in human clinical trials?
No. As of 13 October 2026 the only ClinicalTrials.gov record naming Melanotan II, a Phase 2 vitiligo study (NCT07437560), describes itself in its own summary as an "example interventional study record". It is one of eight such registrations from one sponsor. Its relatives afamelanotide (Scenesse) and bremelanotide (Vyleesi) are approved drugs with their own trial records. They are different molecules.
Related reading
What it's researched for
- melanogenesis and pigmentation research
- melanocortin receptor pharmacology
- appetite and libido signaling models
Where to source it
ALL 3 VENDORS →RANKED BY COMPOSITE SCORE · PRICES ARE SNAPSHOTS FROM THE PRICE INDEX · PER-MG IS A WITHIN-COMPOUND COMPARATOR
Frequently asked about Melanotan 2
What is Melanotan 2?
Melanotan 2 is a synthetic, cyclized analog of alpha-melanocyte-stimulating hormone (α-MSH). It is a non-selective melanocortin-receptor agonist studied for melanogenesis (via MC1R) and for appetite and sexual-function signaling (via MC4R).
What is the difference between Melanotan 2 and PT-141?
Melanotan 2 is a non-selective melanocortin agonist (hits MC1R and MC4R). PT-141 (bremelanotide) is a metabolite-derived, MC4R-selective agonist studied specifically for sexual-function signaling without the strong pigmentation effect. They are related but distinct compounds.
Is Melanotan 2 FDA-approved?
No. Melanotan 2 is not approved by the FDA or EMA for any use. Vendor-sold MT-2 is research-grade material, not a medicine.
How do I verify Melanotan 2 purity?
Check for a per-batch Certificate of Analysis with HPLC purity and mass-spec identity and run it through our /tools/coa-verifier. Note that some vendors label it "MT-2" or "Melanotan II" — confirm the COA matches the vial.